Nicholas Heimann

Nicholas Heimann

Company: Nicholas Pharmaceuticals

Job title: Chief Executive Officer


Resurrecting and Supporting the Immune Response with Combination Therapy to Cure Pancreatic Ductal Adenocarcinoma 9:30 am

• Utilizing therapeutic interventions to create an internal vaccine. • Rational utilization of PD-1 inhibitors in the treatment of PDAC. • Complementing the immune response against cancer with EGFR/KRAS combination therapyRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.